MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 09.02.2026
Becton, Dickinson and Company Betriebsaufwand 2011-2026 | BDX
Betriebsaufwand Jährlich Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 6.05 B | 5.02 B | 4.11 B | 3.83 B | 3.2 B | 2.7 B | 2.92 B | 2.4 B | 2.33 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.05 B | 2.33 B | 3.62 B |
Betriebsaufwand anderer Aktien in der Medizinische Instrumente
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B |  USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | $ 10.9 | 9.0 % | $ 26.4 M | USA |
 |
AtriCure
ATRC
|
410 M | $ 31.07 | -1.26 % | $ 1.48 B | USA |
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M | USA |
 |
Isoray
ISR
|
92.3 M | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 81.93 | -1.73 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
3.37 B | $ 84.0 | 1.13 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Baxter International
BAX
|
3.88 B | $ 19.1 | 0.45 % | $ 9.8 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
368 M | $ 115.62 | -1.86 % | $ 5.6 B | USA |
 |
Haemonetics Corporation
HAE
|
527 M | $ 64.55 | -1.59 % | $ 3.25 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 127.87 | 1.61 % | $ 4.09 B | USA |
 |
Predictive Oncology
POAI
|
11.7 M | - | - | $ 31.1 M | USA |
 |
Harvard Bioscience
HBIO
|
64.2 M | $ 0.58 | 2.14 % | $ 24.6 M | USA |
 |
Repro Med Systems
KRMD
|
27 M | $ 4.88 | 2.2 % | $ 223 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 10.98 | -0.54 % | $ 449 M | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 106.91 | -0.87 % | $ 2.42 B | USA |
 |
Masimo Corporation
MASI
|
1.27 B | $ 175.43 | 0.04 % | $ 9.35 B | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 2.47 | 3.28 % | $ 25.2 M |  Israel |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 20.59 | 2.06 % | $ 949 M | USA |
 |
Nephros
NEPH
|
10 M | $ 3.92 | 1.29 % | $ 40.7 M | USA |
 |
electroCore
ECOR
|
32.5 M | $ 7.9 | 3.81 % | $ 43.6 K | USA |
 |
Envista Holdings Corporation
NVST
|
2.13 B | $ 28.51 | -0.52 % | $ 4.79 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 258.94 | 0.22 % | $ 37.8 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 18.29 | 1.89 % | $ 1.23 B | USA |
 |
Retractable Technologies
RVP
|
20.1 M | $ 0.68 | -3.05 % | $ 20.4 M | USA |
 |
ICU Medical
ICUI
|
779 M | $ 142.18 | -0.34 % | $ 3.5 B | USA |
 |
InfuSystem Holdings
INFU
|
60.9 M | $ 9.57 | 4.25 % | $ 198 M | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 501.88 | 0.9 % | $ 179 B | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 126.05 | 2.43 % | $ 7.02 M | USA |
 |
STERIS plc
STE
|
1.54 B | $ 244.67 | 0.62 % | $ 24.1 B | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 119.41 | -2.24 % | $ 5.33 B | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 74.53 | -0.43 % | $ 4.41 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 67.17 | 0.99 % | $ 244 M | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 19.17 | 1.32 % | $ 950 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 250.46 | -0.3 % | $ 18.1 B | USA |
 |
OraSure Technologies
OSUR
|
108 M | $ 3.0 | 0.67 % | $ 223 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 48.51 | 2.1 % | $ 159 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 13.47 | 1.24 % | $ 2.69 B | USA |
 |
Stereotaxis
STXS
|
36.7 M | $ 2.22 | 3.74 % | $ 179 M | USA |
 |
Milestone Scientific
MLSS
|
13.2 M | $ 0.29 | 2.33 % | $ 23.1 M | USA |